Doctor profile · Federal record
Dr. Thomas Williamson, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Winston Salem, NC
- NPI 1023429941
- Accepts Medicare
- MIPS 98.8 / 100 · 2023
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1 Medical Center Blvd
Winston Salem, NC 271570001
(336) 716-6777 - Mailing address
-
1227 N State St Ste 101
Jackson, MS 392022002
Credentials & registration
- NPI registered
- May 2014 — 12 yrs on file
- Profile last updated
- September 14, 2023
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Mississippi #24656
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023429941. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
178,262
Distinct HCPCS
10
Medicare allowed
$2,998,230
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 54,000 | 38 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 22,400 | 32 | $47 | |
J0185 |
Injection, aprepitant, 1 mg | 19,890 | 47 | $2 | |
J9299 |
Injection, nivolumab, 1 mg | 18,160 | 12 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 12,240 | 42 | $23 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 9,800 | 11 | $0 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 6,030 | 14 | $42 | |
J9267 |
Injection, paclitaxel, 1 mg | 4,980 | 13 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 4,900 | 14 | $5 | |
J9311 |
Injection, rituximab 10 mg and hyaluronidase | 4,260 | 11 | $37 |
In context: peer comparison
Among 23 peers in this city , average services per provider: 1,007. This provider delivers 177× the peer median.Open Payments
Industry payments received
All-time total
$2,198
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo Inc. | 7 | $217.14 | |
| Gilead Sciences, Inc. | 7 | $208.74 | |
| Celgene Corporation | 9 | $168.35 | |
| Janssen Biotech, Inc. | 10 | $167.28 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $127.77 | |
| Merck Sharp & Dohme LLC | 6 | $109.54 | |
| Genentech USA, Inc. | 6 | $103.31 | |
| AstraZeneca Pharmaceuticals LP | 6 | $95.95 | |
| PFIZER INC. | 7 | $93.78 | |
| Pharmacosmos Therapeutics Inc. | 3 | $73.59 | |
| Lilly USA, LLC | 3 | $67.65 | |
| Novartis Pharmaceuticals Corporation | 4 | $63.51 | |
| GENZYME CORPORATION | 3 | $63.28 | |
| Incyte Corporation | 3 | $61.81 | |
| Deciphera Pharmaceuticals Inc. | 3 | $55.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
853
Patients
217
Total drug cost
$1,679,506
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 121 | 40 | $2,893 |
| Dexamethasone | Generic | 85 | 26 | $1,914 |
| Hydroxyurea | Generic | 79 | 18 | $2,403 |
| Gabapentin | Generic | 74 | 18 | $896 |
| Eliquis (Apixaban) | Brand | 72 | 12 | $53,058 |
| Imbruvica (Ibrutinib) | Brand | 70 | 0 | $864,424 |
| Potassium Chloride | Generic | 57 | 20 | $834 |
| Ondansetron Odt (Ondansetron) | Brand | 55 | 36 | $1,478 |
| Acyclovir | Generic | 45 | 23 | $566 |
| Anastrozole | Generic | 37 | 0 | $398 |
Hospital affiliations
Frequently asked questions
What is Dr. Thomas Williamson's medical specialty?
Dr. Thomas Williamson practices Hematology & Oncology Physician in Winston Salem, NC.
Where does Dr. Thomas Williamson practice?
Dr. Thomas Williamson practices at 1 Medical Center Blvd, Winston Salem, NC 271570001. Office phone: 3367166777.
What is Dr. Thomas Williamson's NPI?
Dr. Thomas Williamson's National Provider Identifier (NPI) is 1023429941, issued by NPPES.
Does Dr. Thomas Williamson accept Medicare assignment?
Yes. Dr. Thomas Williamson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Thomas Williamson commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.